OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Charity No. 1159476

Trustees' Report and Unaudited Accounts

31 March 2025

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA Contents

Pages
Trustees' Annual Report 2 to 8
Independent Examiner's Report 9
Statement of Financial Activities 10
Balance Sheet 11
Notes to the Accounts 12 to 19
Statement of Cash flows 20
Detailed Statement of Financial Activities 21 to 22

Page 1

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Trustees Annual Report

British Society For Spondyloarthritis

The trustees present their report with the unaudited financial statements of the charity for the year ended 31 March 2025.

REFERENCE AND ADMINISTRATIVE DETAILS

Charity No. 1159476

Principal Office

C/O Professor JK Gaffney

Dept of Rheumatology, Level 2 Outpatients East

Norfolk and Norwich University Hospital Colney Lane, Norwich NR4 7UY

Trustees

The following trustees served during the year:

A. Bennett

J.K. Gaffney H. Marzo-Ortega R. Sengupta S. Siebert D.R.A. Webb

Accountants

Andrew Parker Associates Ltd Unit 7

Beech Avenue Business Park Beech Avenue, Taverham Norwich NR8 6HW

Page 2

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Trustees Annual Report

OBJECTIVES AND ACTIVITIES

The Trustees present their annual report together with the financial statements of the British Society for Spondyloarthritis (the charity) for the period ended 31 March 2025. The Trustees confirm that the Annual report and financial statements of the charity comply with the current statutory requirements, the requirements of the charity's governing document and the provisions of the Statement of Recommended Practice (SORP), applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

Chair's report 2025

BRITSpA-supported national research studies are under development and the charity continues to collaborate with a partner charity and academic groups to promote a range of studies. We were delighted to see the progress of the BAxSIC study looking at the impact of the delay of diagnosis in the inception cohort of axSpA patients. Membership continues to increase steadily and includes the full range of health care professionals and scientists committed to the advancement of knowledge and treatment of spondyloarthritis. The 2024 Annual Scientific meeting was well-attended and attracted very positive feedback. BRITSpA continues to support Travelling Fellowships for members to facilitate sharing of best practice in axSpA. BRITSpA has also established a regular education programme for healthcare professionals in the UK.

Prof Raj Sengupta, Chair of Trustees

OBJECTIVES OF THE CHARITY

The objectives of the charity are to promote the education of health care specialists and the public in relation to all aspects of the spondyloarthritis group of diseases including axial spondyloarthritis, psoriatic arthritis, reactive arthritis, arthritis related to inflammatory bowel disease and undifferentiated peripheral arthritis, to share information and skills among different medical disciplines that deal with these types of conditions and related disorders and to enhance research, diagnosis and treatment of spondyloarthritis for the benefit of those suffering from these conditions.

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

ACTIVITIES FOR ACHIEVING OBJECTIVES

The principal activities for achieving these objectives are:

Page 3

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Trustees Annual Report

MAIN ACTIVITIES UNDERTAKEN TO FURTHER THE CHARITY'S PURPOSES FOR PUBLIC BENEFIT FOR THE PERIOD 2024-25

(i) Provision of multidisciplinary educational meetings

The two-day Annual Scientific Meeting's programme is designed to benefit and be accessible to all members across their various professional roles. A further separate educational day has been established, the first of which to take place 14th May 2025 at Goodenough College, London.

(ii) Establishment and advocacy of best practice for clinicians

The Annual Scientific meeting allows the sharing of best practice. Delegates are able to interact and network with the lecturers via Q&A. The latest developments and guidelines are shared with the membership.

(iii) Sharing of skills among the different medical disciplines Current membership continues to grow, standing currently at 207, following a revalidation exercise, with approximately equal numbers of Rheumatology Consultants and allied health professionals. The Travelling Fellowship grant is available for all members to visit other centres to share best practice.

(iv) Facilitation of research into aspects of spondyloarthritis BRITSpA members are contacted regularly by email and website notifications regarding studies of interest.

v) Improvement of diagnosis and treatment of spondyloarthritis All of the activities of BRITSpA are aimed at improving the recognition of SpA amongst clinicians and allied health professionals, and refining and understanding current and emerging treatment modalities, particularly with a view to reducing the delay to diagnosis. Guest speakers at the Annual Scientific Meeting share expertise from across the UK and Europe.

vi) Conform to GDPR regulations

The charity’s policy is shown on the website. Members are advised regularly how to request deletion of their details. A revalidation process took place early in 2025 to update the membership and conform to GDPR.

(vii) Broaden Executive Committee to reflect membership and broaden expertise The Executive Committee currently comprises eight Rheumatology Consultants, one scientist, and one physiotherapist. A further AHP role is being advertised.

(viii) Extend representation of BRITSpA and axSpA on professional bodies

Page 4

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Trustees Annual Report

Executive committee members sit on:

Page 5

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Trustees Annual Report

Structure, governance and management CONSTITUTION The principal objective of the charity is to promote the education of the public and health care specialists in relation to all aspects of the spondyloarthritis group of diseases, and to share information and skills among different medical disciplines. The registered charity, number 1159476, is constituted under a Trust deed dated 3rd December 2014. The British Society for Spondyloarthritis (BRITSpA) was set up as a charitable Trust by five of the current Trustees who are also founder members of the Executive Committee governing the activities of the Trust.

The Trust actively fundraises. In the first instance this is mainly through approaches to pharmaceutical companies with an interest in advancing knowledge of spondyloarthritis. There is a donate button the charity website. The risk of potential conflicts of interest has been acknowledged from the inception of BRITSpA; there is no representation of pharmaceutical companies or other potential donors on the Executive Committee and the measures taken to ensure that all funding and expenditure are transparent and in line with the society’s charitable status and objectives and set out in the financial report below.

The Trustees and Executive Committee have met quarterly since the charity's inception, together with regular minuted teleconferences and e- meetings. The Executive Committee has two in-person meetings annually and 6-9 Teams meetings. Any practical changes to the charity bylaws are circulated prior to the AGM and voted upon by the attending membership. All Trustees give their time freely and no Trustee remuneration was paid in the year. Details of Trustee expenses and related party transactions are disclosed in the accounts. Neither the Trust nor any of the Trustees have interests with the pharmaceutical industry but any such interests would be disclosed. Members of the Executive Committee (EC) were affirmed. At the Trustees’ meetings, the broad strategy and areas of activity for the charity and plans for research, education and links with other professional and patient groups are agreed. The day to day administration of the charity’s activities is managed by the Executive Committee members, assisted by the administrator.

METHOD OF APPOINTMENT OR ELECTION OF TRUSTEES

The management of the charity is the responsibility of the Trustees who are elected and co-opted under the terms of the charity Bylaws, which are published on the BRITSpA website.

ORGANISATIONAL STRUCTURE AND DECISION MAKING

The Executive Committee is responsible for overall policy and direction of BRITSpA, and delegates responsibility for day-to-day operations to the administrator. Sub-committees are formed for separate research projects, as applicable. All the Executive Committee will be eligible for re-election, with no more than half of the Executive Committee to be changed at one time.

EMPLOYEES OF THE CHARITY

BRITSpA employs a part-time administrator (appointed 7th January 2015), originally for three days a week: this role was reduced to one day a week from May 2020, then reviewed and increased to two days a week from March 2021 until the present day.

MEMBERSHIP AND LINKS WITH RELATED PROFESSIONAL GROUPS

Recruitment to membership of BRITSpA continues to be successful with a current membership of 209 including Rheumatologists, both Consultants and trainees, nurses, radiologists, physiotherapists and occupational therapists, scientists, Research Fellows, epidemiologists, chiropractors and general practitioners with an established interest.

We maintain our close relationship with patient-centred charity National Ankylosing Spondylitis Society (NASS), and count the CEO and three other staff among our membership. BRITSpA EC members remain as trustees and/or medical advisors to NASS.

Page 6

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Trustees Annual Report

FINANCIAL REVIEW

GOING CONCERN

After making appropriate enquiries, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future, with a minimum balance of £5,000.

The Trustees have considered the Charity's position at the time of signing the financial statements, and in particular the current issues caused by the continuing Covid-19 pandemic and its impact on the Charity and the wider economy. The administrator's working hours have been temporarily reduced.

Based on this, the Trustees have concluded that they have a reasonable expectation that the Charity will have adequate resources to continue in operational existence for the foreseeable future, and the date of signing these financial statements, they continue to adopt the going concern basis of accounting in preparing these financial statements.

RESERVES POLICY

The Treasurer continues to be successful in attracting funding for the Annual Scientific Meetings. Following discussion at the 2022 AGM, a decision was made for member delegates to make nominal contributions to the cost of the meeting by means of delegate fees.

Future options for core funding are continuously explored and are debated during the annual general meeting.

The Trustees have set a reserves policy of a minimum balance of £5,000.

Total unrestricted funds at 31 March 2025 amounted to £51,175 (2024: £36,052 ). Restricted funds amounted to £2,669 (2024: £5,294). Restricted funds are in respect of Travelling Fellowship funding to provide additional training for members, and a donation to fund medals.

PLANS FOR FUTURE PERIODS

The charity’s main focus will be to progress and develop opportunities for members to engage in research, in order to continue share knowledge with regard to all aspects of the spondyloarthritis group of diseases. An annual Educational meeting has been established with meetings organised for May 2025 and 2026.

Statement of trustees' responsibilities in relation to the financial statements

The charity trustees are responsible for preparing a trustees' annual report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the Trust deed. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 7

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Trustees Annual Report

The charity Trustees are responsible for preparing a Trustees' annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the Trust deed. The Trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Trustees are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England & Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of its incoming resources and application of resources, including its income and expenditure for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Signed on behalf of the charity's trustees

R. Sengupta Trustee 12 December 2025

Page 8

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA Independent Examiners Report

Independent Examiner's Report to the trustees of BRITSpA

I report to the trustees on my examination of the financial statements of BRITSpA for the year ended 31 March 2025.

Responsibilities and basis of report

As the charity's trustees you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Andrew Parker ACCA Andrew Parker Associates Ltd

Unit 7

Beech Avenue Business Park

Beech Avenue, Taverham

Norwich

NR8 6HW

12 December 2025

Page 9

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Statement of Financial Activities

for the year ended 31 March 2025

Notes
Income and endowments
from:
Donations and legacies
3
Other trading activities
4
Total
Expenditure on:
Charitable activities
5
Other
6
Total
Net gains on investments
Net income
7
Transfers between funds
Net income before other
gains/(losses)
Other gains and losses
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
Unrestricted
funds		 Restricted
funds		 Total funds Total funds
2025 2025 2025 2024
£ £ £ £
97,567 - 97,567 62,550
300 - 300 -
97,867 - 97,867 62,550
58,323 2,625 60,948 40,218
24,421 - 24,421 17,243
82,744 2,625 85,369 57,461
- - - -
15,123 (2,625) 12,498 5,089
- - - -
15,123 (2,625) 12,498 5,089
15,123 (2,625) 12,498 5,089
36,052 5,294 41,346 36,257
51,175 2,669 53,844 41,346

Page 10

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Balance Sheet

at 31 March 2025

at 31 March 2025
BRITSpA
Balance Sheet
Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D
Charity No. 1159476 2025 2024
£ £
Fixed assets
Tangible assets 9 633 144
633 144
Current assets
Debtors 10 179 792
Cash at bank and in hand 54,530 41,538
54,709 42,330
Creditors:Amount falling due within one year 11 (1,498) (1,128)
Net current assets 53,211 41,202
Total assets less current liabilities 53,844 41,346
Net assets excluding pension asset or liability 53,844 41,346
Total net assets 53,844 41,346
The funds of the charity
Restricted funds 12
Restricted income funds 2,669 5,294
2,669 5,294
Unrestricted funds 12
General funds 51,175 36,052
51,175 36,052
Reserves 12
Total funds 53,844 41,346

Approved by the trustees on 12 December 2025

And signed on their behalf by:

R. Sengupta Trustee 12 December 2025

Page 11

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Notes to the Accounts

for the year ended 31 March 2025

Basis of preparation

The financial statements have been prepared in accordance with Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic if Ireland (FRS 102) issued on 16 July 2014 and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011.

Change in basis of accounting or to previous accounts

There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.

Fund accounting

Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity.

Income

Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets

Page 12

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Notes to the Accounts

Expenditure

Taxation

The charity is exempt from tax on its charitable activities.

Tangible fixed assets and depreciation

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:

Office equipment 25% Reducing balance

Freehold investment property

Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.

Stocks

Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.

Trade and other debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.

Page 13

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Notes to the Accounts

Trade and other creditors

Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Foreign currencies

Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period. Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred. All exchange differences are are taken into account in arriving at net income/expenditure.

Leased assets

Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease. Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.

Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs. Assets held under finance leases are depreciated in the same way as owned assets.

Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.

Pension costs

The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the charity pays fixed contributions into a separate entity. Once the contributions have been paid the charity has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the charity in independently administered funds.

Receipt of donated goods, facilities and services

All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.

Page 14

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Notes to the Accounts

2 Statement of Financial Activities - prior year

Income and endowments from:
Donations and legacies
Total
Expenditure on:
Charitable activities
Other
Total
Net income
Net income before other
gains/(losses)
Other gains and losses:
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
3
Income from donations and legacies
Donations & sponsorship
4
Income from other trading activities
Sundry income		 Unrestricted
funds
2024
£
52,550
52,550
37,167
3,597
40,764
11,786
11,786
11,786
24,266
36,052
Unrestricted
£
97,567
97,567
Unrestricted
£
300
300		 Restricted
funds
2024
£
10,000
10,000
2,971
13,726
16,697
(6,697)
(6,697)
(6,697)
11,991
5,294
Total
2025
£
97,567
97,567
Total
2025
£
300
300		 Total funds
2024
£
62,550
62,550
40,138
17,323
57,461
5,089
5,089
5,089
36,257
41,346
Total
2024
£
62,550
62,550
Total
2024
£
-
-

Page 15

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Notes to the Accounts

5 Expenditure on charitable activities

Expenditure on charitable
activities
Event organisation
Travelling
Governance costs
6
Other expenditure
Employee costs
Motor and travel costs
Premises costs
Amortisation, depreciation,
impairment, profit/loss on
disposal of fixed assets
General administrative costs
Legal and professional costs
7
Net income before transfers
This is stated after charging:
Depreciation of owned fixed assets
8
Staff costs
Salaries and wages
Pension costs		 Unrestricted
£
58,323
-
-
58,323		 Restricted
£
-
2,625
-
2,625
Unrestricted
£
14,736
1,881
521
211
5,549
1,523
24,421
2025
£
211
2025
14,176
560
14,736		 Total
2025
£
58,323
2,625
-
60,948
Total
2025
£
14,736
1,881
521
211
5,549
1,523
24,421		 Total
2024
£
37,167
2,971
80
40,218
Total
2024
£
13,730
958
259
202
316
1,778
17,243
2024
£
48
2024
13,086
560
13,646

No employee received emoluments in excess of £60,000.

Page 16

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Notes to the Accounts

9 Tangible fixed assets

Cost or revaluation
At 1 April 2024
Additions
At 31 March 2025
Depreciation and
impairment
At 1 April 2024
Depreciation charge for the
year
At 31 March 2025
Net book values
At 31 March 2025
At 31 March 2024
10 Debtors
Other debtors
11 Creditors:
amounts falling due within one year
Other taxes and social security
Accruals		 2025
£
179
179
2025
£
370		 Office
equipment
£
539
700
1,239
395
211
606
633
144		 Total
£
539
700
1,239
395
211
606
633
144
2024
£
792
792
2024
£
-
1,128 1,128
1,498 1,128

Page 17

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Notes to the Accounts

12 Movement in funds

Restricted funds:
Restricted income funds:
Total
Unrestricted funds:
General funds
Total funds
13 Analysis of net assets between funds
Fixed assets
Net current assets
14 Reconciliation of net debt
Cash and cash equivalents
Net debt		 At 1 April
2024
5,427
(133)
5,294
36,052
41,346		 Incoming
resources
(including
other
gains/losses
)
£
-
-
-
97,867
97,867
At 1 April
2024
£		 Resources
expended
£
(2,758)
133
(2,625)
(82,744)
(85,369)
Unrestricted
funds
£
633
53,211
53,844
Cash flows
£		 At 31
March
2025
£
2,669
-
2,669
51,175
53,844
Total
£
633
53,211
53,844
At 31
March
2025
£
41,538 12,992 54,530
41,538
41,538		 12,992
12,992		 54,530
54,530

Page 18

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Notes to the Accounts

15 Commitments

Operating lease commitments

Annual commitments under non-cancellable operating leases are as follows:

2025 2025 2024 2024
Land and Land and
Other Other
buildings buildings
£ £ £ £
Operating leases with expiry date:
Pension commitments
2025 2024
£ £
The pension cost charge to the charity
amounted to: 560 560

Page 19

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D BRITSpA

Statement of Cash flows

for the year ended 31 March 2025

Cash flows from operating activities
Net income per Statement of Financial Activities
Adjustments for:
Depreciation of property, plant and equipment
Loss on disposal of tangible fixed assets
Decrease in trade and other receivables
Increase in trade and other payables
Net cash provided by operating activities
Cash flows from investing activities
Payments for property, plant and equipment
Net cash used in investing activities
Net cash from financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year		 2025
£
12,498
211
-
613
370
13,692
(700)
(700)
-
12,992
41,538
54,530		 2024
£
5,089
48
154
2,411
156
7,858
-
-
-
7,858
33,680
41,538
Components of cash and cash equivalents
Cash and bank balances 54,530 41,538
54,530 41,538

Page 20

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Detailed Statement of Financial Activities

for the year ended 31 March 2025

Income and endowments from:
Donations and legacies
Donations & sponsorship
Other trading activities
Sundry income
Total income and endowments
Expenditure on:
Charitable activities
Event organisation
Travelling
Governance costs
Total of expenditure on charitable
activities
Employee costs
Salaries/wages
Pension costs
Staff welfare
Motor and travel costs
Travel and subsistence
Premises costs
Rent
General administrative costs,
including depreciation and
amortisation
Depreciation of Office
equipment
Loss on disposal of tangible fixed
assets
Bank charges
Software, IT support and related
costs		 Unrestricted
funds
2025
£
97,567		 Restricted
funds
2025
£
-		 Total funds
2025
£
97,567		 Total funds
2024
£
62,550
97,567 - 97,567 62,550
300 - 300 -
300 - 300 -
97,867
58,323
-		 -
-
2,625		 97,867
58,323
2,625		 62,550
37,167
2,971
58,323 2,625 60,948 40,138
- - - 80
- - - 80
58,323
14,176
560
-		 2,625
-
-
-		 60,948
14,176
560
-		 40,218
13,086
560
84
14,736 - 14,736 13,730
1,881 - 1,881 958
1,881 - 1,881 958
521 - 521 259
521 - 521 259
211
-
103
334		 -
-
-
-		 211
-
103
334		 48
154
105
200

Page 21

Docusign Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F39650D

BRITSpA

Detailed Statement of Financial Activities

BRITSpA
Detailed Statement of Financial Activities
Envelope ID: A42F3C34-58B8-4ECF-ABB1-523D8F3965		 0D
Stationery and printing
Subscriptions
Sundry expenses
Legal and professional costs
Accountancy and bookkeeping
Total of expenditure of other costs
Total expenditure
Net gains on investments
Net income
Net income before other
gains/(losses)
Other Gains
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward		 4,395
180
537		 -
-
-		 4,395
180
537		 11
-
-
5,760 - 5,760 518
1,523 - 1,523 1,778
1,523 - 1,523 1,778
24,421 - 24,421 17,243
82,744
-		 2,625
-		 85,369
-		 57,461
-
15,123 (2,625) 12,498 5,089
15,123
-		 (2,625) 12,498
-		 5,089
-
-
15,123 (2,625) 12,498 5,089
41,346 36,257
36,052 5,294
51,175 2,669 53,844 41,346

Page 22